<DOC>
	<DOCNO>NCT03022032</DOCNO>
	<brief_summary>This research study evaluate new smartphone application name `` Helping Our Patients Excel ( HOPE ) '' app Fitbit device . The HOPE app design learn improve quality life</brief_summary>
	<brief_title>The HOPE Trial : Helping Our Patients Excel</brief_title>
	<detailed_description>One goal palliative chemotherapy treatment make patient feel well reduce symptom . Sometimes chemotherapy treatment cause side effect hard figure manage side effect home , even call doctor . Clinicians may also hard time monitor patient ' symptom activity level home , away clinic . The HOPE Trial test new smartphone application—the HOPE app—in woman incurable gynecologic cancer . It design collect information study participant ' health behavior clinic visit help participant manage symptom home . It also give participant information symptom side effect them—and investigator encourage participant share information doctor , though participant require participant choose participate study . The app test two wearable accelerometer : Fitbit Zip Fitbit Charge HR . Wearable accelerometer device wear hip wrist track participant 's movement—for example , many step participant walk day—or heart rate . This research do improve participant ' quality life . investigator hope app wearable accelerometer help reduce participant ' symptom increase activity . It also do understand participant ' experience use HOPE app Fitbits order see investigator improve app determine Fitbit model work best .</detailed_description>
	<criteria>Women &gt; 20 year age Who plan receive chemotherapy DFCI treat recurrent , incurable gynecologic cancer ( ovarian , uterine , cervical ) recur despite ≥1 prior treatment . Own smartphone ( Android iOS ) Capable download run study app assistance Can read provide informed consent English Do cognitive visual impairment would preclude use app . Patients ineligible participate investigational drug treatment trial require structured symptom toxicity reporting time enrollment . Patients severe cognitively impairment Who appear weak Emotionally distraught Agitated ill participate , judge either research study staff oncology provider , exclude . Patients unable provide inform consent English exclude smartphone app intervention available English time . Children young adult age 20 exclude diagnosis metastatic gynecologic cancer age group rare propose instrument design people age . Patients life expectancy ≤6 month , determine oncology provider , exclude since participate require data collection</criteria>
	<gender>Female</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Gynecologic cancer</keyword>
</DOC>